AGL

Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.

What a time it’s been for agilon health. In the past six months alone, the company’s stock price has increased by a massive 275%, reaching $91.76 per share.

How the Jackson Clinic expansion reframes agilon health’s Medicare footprint Agilon health (AGL) just expanded its partnership with The Jackson Clinic, bringing the practice into its Senior Health Connect ACO and extending value-based care reach to roughly…

Here is how Agilon Health (AGL) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.

In September 2026, agilon health announced that Family Practice Center, PC in Pennsylvania would join one of its Senior Health Connect Accountable Care Organizations under a long-term, full-risk value-based care agreement for certain Medicare patients beginning in 2024.

Event overview and why agilon health stock is back on radar agilon health (AGL) drew fresh attention after the share price moved 3.9% higher on September 15, 2026, following an upgrade from Bernstein SocGen Group that highlighted progress in the company’s ongoing turnaround.

Shares of healthcare services company Agilon Health (NYSE:AGL) jumped 3.9% in the morning session after Bernstein SocGen Group upgraded the stock's rating to Outperform from Market Perform and raised its price target from $86 to $125.

Here is how Agilon Health (AGL) and Illumina (ILMN) have performed compared to their sector so far this year.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at agilon health (NYSE:AGL) and the best and worst performers in the outpatient & specialty care industry.

Revenue hit $1.49 billion as medical margins swung sharply positive.

Here is how Agilon Health (AGL) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

Why agilon health stock is in focus after the latest earnings agilon health (AGL) is back on investors’ radar after second quarter results showed a shift from loss to profit, alongside revenue above market expectations and higher full year revenue guidance for 2026.